Kukkutanda Basti (ALBU-PRO Bio-Enemata) vs. Intravenous Albumin in the Management of Hypoalbuminemia: A Comparative Pilot Clinical Study

Authors

  • Dr Dharmesh Chauhan
  • Dr Misbah Rangwala
  • Dr Hemant Toshikhane
  • Dr Anitha H

DOI:

https://doi.org/10.63001/tbs.2026.v21.i01.pp1015-1025

Keywords:

Kukkutanda Basti,

Abstract

Ayurveda offers a wide spectrum of therapeutic modalities, among which Basti therapy plays
a significant role due to its systemic action through rectal administration. Kukkutanda Basti, a formulation
derived from egg yolk, has been traditionally used to enhance nutritional status. Considering the high cost,
limited efficacy, and adverse reactions associated with intravenous albumin therapy, there is a growing
need to explore affordable and safer Ayurvedic alternatives for managing hypoalbuminemia.
Aim: To evaluate the pharmaceutical characteristics and clinical efficacy of ALBU-PRO Bio-Enemata
(Kukkutanda Basti) and to compare its therapeutic outcomes with standard intravenous albumin
supplementation in patients with hypoalbuminemia.

Downloads

Published

2026-02-12

How to Cite

Dr Dharmesh Chauhan, Dr Misbah Rangwala, Dr Hemant Toshikhane, & Dr Anitha H. (2026). Kukkutanda Basti (ALBU-PRO Bio-Enemata) vs. Intravenous Albumin in the Management of Hypoalbuminemia: A Comparative Pilot Clinical Study. The Bioscan, 21(1), 1015–1025. https://doi.org/10.63001/tbs.2026.v21.i01.pp1015-1025